chr17-30944914-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018404.3(ADAP2):c.518G>T(p.Ser173Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018404.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAP2 | NM_018404.3 | c.518G>T | p.Ser173Ile | missense_variant | 6/11 | ENST00000330889.8 | NP_060874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAP2 | ENST00000330889.8 | c.518G>T | p.Ser173Ile | missense_variant | 6/11 | 1 | NM_018404.3 | ENSP00000329468 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250380Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135318
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461572Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727078
GnomAD4 genome AF: 0.000171 AC: 26AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.518G>T (p.S173I) alteration is located in exon 6 (coding exon 6) of the ADAP2 gene. This alteration results from a G to T substitution at nucleotide position 518, causing the serine (S) at amino acid position 173 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at